GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JFL Life Sciences Ltd (NSE:JFLLIFE) » Definitions » Retained Earnings

JFL Life Sciences (NSE:JFLLIFE) Retained Earnings : ₹89.3 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is JFL Life Sciences Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. JFL Life Sciences's retained earnings for the quarter that ended in Mar. 2024 was ₹89.3 Mil.

JFL Life Sciences's quarterly retained earnings increased from Mar. 2022 (₹28.1 Mil) to Mar. 2023 (₹56.2 Mil) and increased from Mar. 2023 (₹56.2 Mil) to Mar. 2024 (₹89.3 Mil).

JFL Life Sciences's annual retained earnings increased from Mar. 2022 (₹28.1 Mil) to Mar. 2023 (₹56.2 Mil) and increased from Mar. 2023 (₹56.2 Mil) to Mar. 2024 (₹89.3 Mil).


JFL Life Sciences Retained Earnings Historical Data

The historical data trend for JFL Life Sciences's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JFL Life Sciences Retained Earnings Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Retained Earnings
Get a 7-Day Free Trial 12.67 18.10 28.10 56.22 89.30

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Retained Earnings Get a 7-Day Free Trial 12.67 18.10 28.10 56.22 89.30

JFL Life Sciences Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


JFL Life Sciences  (NSE:JFLLIFE) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


JFL Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.

JFL Life Sciences Headlines

No Headlines